Gene · 634
Papers3,222
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,222
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification and Experimental Validation of PANoptosis Key Genes for Constructing a PANoptosis Risk Diagnostic Model in Intervertebral Disc Degeneration. | J Gene Med | 2026 | 42803180 | PubTator, text mining | PubMed |
| Diurnal Insulin Clearance and Circadian Metabolic Gene Signatures in MASLD: Integrative Multi-Dataset Physiological and Transcriptomic Analysis. | Metabolites | 2026 | 42783754 | PubTator, text mining | PubMed |
| Protective effects and mechanisms of puerarin in ovariectomized animal models of osteoporosis: a systematic review and meta-analysis of preclinical studies. | Front Physiol | 2026 | 42724066 | PubTator, text mining | PubMed |
| The anti-CEACAM1 agonistic antibody CCM5.01 inhibits the growth of colon cancer cell lines in 2D and 3D models. | Pharmacol Rep | 2026 | 42671771 | PubTator, text mining | PubMed |
| Structural basis and preclinical efficacy of MG1124, a novel CEACAM1-targeting antibody synergizing with PD-1 blockade. | Mol Cancer Ther | 2026 | 42658691 | PubTator, text mining | PubMed |
| Zinc finger protein 600 is essential for the cytotoxic function of esophageal cancer-associated natural killer cells. | J Leukoc Biol | 2026 | 42647748 | PubTator, text mining | PubMed |
| Molecular and immune profiling of HER2-low, HER2 ultra-low, and HER2-null male breast cancer. | Breast | 2026 | 42612560 | PubTator, text mining | PubMed |
| Dual Role of Tamoxifen in Enhancing STING and CEACAM1 Expression to Prime a Favorable Tumor Microenvironment for Anti-TIM3 Immunotherapy. | Adv Sci (Weinh) | 2026 | 42606075 | PubTator, text mining | PubMed |
| SETD5 regulates leukemic initiation and infiltration in T-cell acute lymphoblastic leukemia. | Exp Cell Res | 2026 | 42595290 | PubTator, text mining | PubMed |
| Proteome-wide interaction study of fatty acids and mortality in the UK Biobank. | Br J Nutr | 2026 | 42572017 | PubTator, text mining | PubMed |
| Macropinocytosis of neutrophil extracellular trap by gastric cancer cells promotes immune escape and peritoneal metastasis. | Gut | 2026 | 42521486 | PubTator, text mining | PubMed |
| Translational Gap in Biomarker Discovery: Tumor Surface Markers Rarely Mirror Circulating Levels. | Ann Gastroenterol Surg | 2026 | 42495661 | PubTator, text mining | PubMed |
| Biodistribution of tumor-targeted MXene-antibody conjugates. | Biomater Sci | 2026 | 42458933 | PubTator, text mining | PubMed |
| CEACAM1 participation in breast cancer progression. | Mol Oncol | 2026 | 42429399 | PubTator, text mining | PubMed |
| miR-4687-3p modulates cell proliferation and migration in cervical cancer cells. | Mol Biol Rep | 2026 | 42377617 | PubTator, text mining | PubMed |
| CEACAM1 expression by immunohistochemistry in B-cell lymphomas and plasma cell myeloma. | Am J Clin Pathol | 2026 | 42370856 | PubTator, text mining | PubMed |
| Multi-omics biomarkers of endothelial dysregulation preceding chronic lung allograft dysfunction: A prospective cohort study. | PLoS Med | 2026 | 42335172 | PubTator, text mining | PubMed |
| Endocytic CEACAM receptor loss and lack of positive selection in CEACAM1 of birds and snakes indicate absence of pathogen-CEACAM1 interactions in some reptiles. | Res Sq | 2026 | 42326494 | PubTator, text mining | PubMed |
| C4BP occludes the non-opsonic interaction of Neisseria gonorrhoeae with human neutrophil CEACAMs. | Infect Immun | 2026 | 42267928 | PubTator, text mining | PubMed |
| β-Hydroxybutyric acid impairs host antimicrobial defense by targeting the CEACAM1-NADPH-ROS axis to disrupt macrophage bactericidal activity. | Biochem Pharmacol | 2026 | 42263881 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/634/papers